Eli Lilly - 46 Year Stock Price History | LLY

Historical daily share price chart and data for Eli Lilly since 1972 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Eli Lilly as of November 12, 2018 is 113.20.
Eli Lilly Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 90.1573 83.0317 115.4600 72.7655 113.2000 36.69%
2017 79.6250 71.2851 86.1792 71.2659 82.8160 17.83%
2016 72.0794 77.1231 78.8558 63.0385 70.2817 -10.37%
2015 72.4836 63.5187 83.2203 62.4661 78.4167 25.37%
2014 55.0992 44.5194 66.0301 44.5194 62.5486 39.75%
2013 45.4000 41.8964 49.8127 41.4150 44.7564 7.24%
2012 36.1157 33.7797 45.0667 31.4971 41.7356 24.27%
2011 29.0366 26.8063 33.7393 26.1226 33.5858 25.15%
2010 26.2244 25.9559 28.7474 24.0381 26.8369 3.71%
2009 24.2141 27.8060 27.8060 19.0787 25.8762 -6.25%
2008 30.4694 34.4878 37.5264 20.4998 27.6004 -21.23%
2007 35.8763 33.2600 38.8516 32.2171 35.0391 5.65%
2006 34.5632 35.4444 36.8070 31.6204 33.1645 -5.16%
2005 33.5340 33.8090 36.7640 30.5225 34.9686 2.52%
2004 39.1392 41.9053 45.0714 30.1247 34.1095 -17.55%
2003 36.9916 38.1419 43.4641 31.0971 41.3701 13.14%
2002 36.9723 44.3284 45.7507 27.4318 36.5642 -17.56%
2001 44.7244 50.9669 50.9669 40.5753 44.3510 -14.44%
2000 43.5735 36.0080 60.0515 30.0597 51.8358 41.92%
1999 41.2917 46.6528 52.9979 33.6761 36.5243 -24.25%
1998 38.5312 36.9826 49.3001 31.3425 48.2151 29.08%
1997 27.9992 19.1070 37.5190 19.1070 37.3527 94.15%
1996 16.4578 14.2805 20.8860 12.7643 19.2388 32.64%
1995 10.2019 8.1308 14.5693 7.8355 14.5049 77.39%
1994 6.8849 7.0734 8.1769 5.7195 8.1769 15.60%
1993 6.0150 6.9742 7.2211 5.1403 7.0734 2.47%
1992 7.6466 9.3423 9.5888 6.6307 6.9026 -24.89%
1991 8.4370 7.8409 9.3423 7.4367 9.1904 16.41%
1990 7.6380 7.2064 9.5653 6.2636 7.8948 9.95%
1989 5.8992 4.3798 7.1802 4.3798 7.1802 64.17%
1988 4.1872 3.9641 4.6560 3.5292 4.3737 12.81%
1987 4.3478 3.6664 5.1660 3.0615 3.8771 5.75%
1986 3.4468 2.7097 4.0738 2.5122 3.6664 33.18%
1985 2.0941 1.6019 2.7529 1.5986 2.7529 68.94%
1984 1.5033 1.4690 1.6512 1.3332 1.6295 14.03%
1983 1.5468 1.4167 1.6883 1.4011 1.4290 0.66%
1982 1.4050 1.3764 1.6048 1.1481 1.4196 2.68%
1981 1.4400 1.5554 1.6851 1.1510 1.3826 -11.98%
1980 1.3157 1.4320 1.5707 1.1387 1.5707 6.71%
1979 1.3655 1.1851 1.5678 1.1757 1.4720 24.86%
1978 1.1110 0.9320 1.3271 0.9073 1.1789 26.06%
1977 0.9580 1.1634 1.1634 0.8118 0.9352 -20.46%
1976 1.2735 1.2621 1.4814 1.0770 1.1757 -7.75%
1975 1.6235 1.6572 1.9534 1.2562 1.2745 -24.09%
1974 1.7122 1.8117 2.0275 1.3888 1.6789 -8.11%
1973 2.0149 1.9534 2.2621 1.7312 1.8270 -7.06%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $118.867B $22.871B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $389.933B 18.28
Pfizer (PFE) United States $263.593B 14.86
Novartis AG (NVS) Switzerland $206.763B 17.67
Merck (MRK) United States $201.837B 17.49
AbbVie (ABBV) United States $133.559B 11.85
Sanofi (SNY) France $114.344B 14.16
Novo Nordisk (NVO) Denmark $109.812B 17.83
AstraZeneca (AZN) United Kingdom $103.773B 12.88
GlaxoSmithKline (GSK) United Kingdom $102.421B 13.77
Bristol-Myers Squibb (BMY) United States $87.143B 14.35